Talk:Lisinopril/Archive 1

panama
A latebreaking news item on Lisinopril concerning suspected toxic effects of a batch of this drug in Panama:

http://www.arabtimesonline.com/arabtimes/breakingnews/view.asp?msgID=12617 — Preceding unsigned comment added by 151.200.59.48  (talk • contribs) 07:48, 7 October 2006 (UTC)


 * (11.05.07) the above link is no longer valid -SQM — Preceding unsigned comment added by 74.192.157.26 (talk • contribs) 19:04, 5 November 2007 (UTC)

Death as a side effect
saying that death is a serious side effect requiring immediate attention is more than slightly silly. now, the manufacturer may feel they have to list it on the package insert as part of their legal bs, but i don't see where that requires wp to follow suit. it looks ridiculous.Toyokuni3 (talk) 16:21, 9 December 2009 (UTC)

rash side effects
The VA switched me to lisinopril from Benazepril since the latter wasn't on their forumulary. I put up with an increase in epidermal growth only on my palms for about six years until by chance my sister in law mentioned that she had a similar hand rash after starting lisinopril. I got another doctor to switch me back to Benazepril and that rash quickly went away. Although the article states that there is no apparent serum binding, there must be some interaction with the cellular proliferation system upstream of the stratum corneum. — Preceding unsigned comment added by Celhardt (talk • contribs) 12:29, 31 January 2011 (UTC)

Operating Machines
My bottle of this gives a warning in that it may cause difficulty using machines. Can someone discuss that here? Jokem (talk) 17:55, 22 March 2012 (UTC) gg — Preceding unsigned comment added by 68.33.74.204 (talk) 22:26, 2 December 2012 (UTC)

Edits made on 11/4/15
-Improved the "Adverse events" section by adding percentages, updating citations, and separating observed adverse events by disease state (hypertension, acute myocardial infarction, and heart failure; the three disease states studied in clinical trials cited in the manufacturer's package insert)

-Added hyperlinks for medical terminology in adverse events section.

-Updated the "Special populations" section to include people with kidney disease. Also re-wrote the pregnancy and lactation section for increased clarity and changed the pregnancy category from C to D.

-Relocated picture of the crystal structure of ACE-Lisinopril complex to improve article aesthetics

-Removed citations in "Medical uses," "Adverse effects," and "Special populations that linked to non-reputable sources (lisinopril.com, a Cleveland Clinic case study, and health blogs)

Hamptons29 (talk) 05:23, 9 November 2015 (UTC)

Re: Edits made on 11/4/15
1) Yes, draft reflects a neutral point of view.

2) No, a few sections lack proper citation.

3) Recommendations:

We recommend individual citations be included for the percentages listed in the adverse effects section, adding a lead sentence prior to listing the contraindicated populations, removing the recommendations regarding specific creatinine clearance since this is patient-specific and needs to be determined by a trained professional. We also recommend adding a separate section detailing lisinopril’s mechanism of action. Furthermore, it is best to avoid medical terms such as nephrotoxic, dialyzable, hyperkalemic, embryolethality and teratogenicity or alternatively, explain them if lay language is not available or appropriate. Lastly, we recommend adding citations in the “Contraindications” and “Pharmacokinetics and Metabolism” section. Keppra28 (talk) 05:35, 9 November 2015 (UTC)

Final Edits: 11/11/15

 * Added an introductory sentence for the contraindications section
 * Added an introductory sentence for the special populations section
 * Added a section detailing the mechanism of action of lisinopril
 * Substituted complex medical terminology with lay language where appropriate. Added hyperlinks to complex terms deemed essential to the article.
 * Completely re-wrote pharmacokinetics section. Removed material that appeared to be plagiarized from package insert. Added appropriate citations.

Hamptons29 (talk) 06:24, 12 November 2015 (UTC)

Wiki Education Foundation-supported course assignment
This article was the subject of a Wiki Education Foundation-supported course assignment, between 27 August 2019 and 13 December 2019. Further details are available on the course page. Student editor(s): Burtoj10, Albertj9.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 09:14, 18 January 2022 (UTC)

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Sryoung29, Tealeaf29, SelfieChamps 29, Hamptons29. Peer reviewers: Cvu28, Keppra28, Jzhang28, Druginfo28.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 09:14, 18 January 2022 (UTC)

Wiki Education assignment: PHMD 2040 Service - Learning
— Assignment last updated by JustinxLane (talk) 21:17, 1 December 2022 (UTC)

Wiki Education assignment: PHMD 2040 Service - Learning
— Assignment last updated by Ninaanastasio (talk) 17:33, 19 March 2023 (UTC)

Wiki Education assignment: PHMD 2040 Service - Learning
— Assignment last updated by JustinxLane (talk) 19:43, 26 May 2023 (UTC)

Lisinopril drug
Composition of Lisinopril drug 2404:3100:140A:C592:1:0:2F89:7722 (talk) 05:20, 27 August 2023 (UTC)


 * By their names 2404:3100:140A:C592:1:0:2F89:7722 (talk) 05:20, 27 August 2023 (UTC)
 * Full name 2404:3100:140A:C592:1:0:2F89:7722 (talk) 05:21, 27 August 2023 (UTC)